Publications:205
Sanjay J Mathew, MD
About Me
Dr. Mathew is Assistant Professor of Psychiatry at Mount Sinai School of Medicine, and an attending physician at the Mood and Anxiety Disorders Program (MAP). His primary areas of research include MRI and proton MRS in anxiety and mood disorders, and experimental therapeutic approaches across these conditions using novel pharmacotherapies and brain intervention techniques. He is the recipient of a Career Development Award from NIMH to study the neurochemistry of GAD, and in collaboration with Dr. Dikoma Shungu at Weill Medical College of Cornell University, has CFIDS Association grant funding to compare the neurochemistry of GAD patients with CFS patients. He has received numerous awards for his research, including the American College of Neuropsychopharmacology Memorial Travel Award, American Psychiatric Association Lilly Resident Research Award, the Anxiety Disorders Association of America Trainee Travel Award, and grants from the National Alliance for Research on Schizophrenia and Depression, and the American Foundation for Suicide Prevention. Dr. Mathew has also won several awards for his teaching, and currently serves as the course director for psychopharmacological teaching for PGY2-4 psychiatry residents at Mount Sinai. He completed his residency in psychiatry and postdoctoral research fellowship at Columbia University's College of Physicians and Surgeons, and medical school at Baylor College of Medicine in Houston, TX, his hometown.
In The News
Dr. Mathew discusses mood disorders in The Daily News feature The Daily Check Up. View the PDF.
Language
Position
About Me
Dr. Mathew is Assistant Professor of Psychiatry at Mount Sinai School of Medicine, and an attending physician at the Mood and Anxiety Disorders Program (MAP). His primary areas of research include MRI and proton MRS in anxiety and mood disorders, and experimental therapeutic approaches across these conditions using novel pharmacotherapies and brain intervention techniques. He is the recipient of a Career Development Award from NIMH to study the neurochemistry of GAD, and in collaboration with Dr. Dikoma Shungu at Weill Medical College of Cornell University, has CFIDS Association grant funding to compare the neurochemistry of GAD patients with CFS patients. He has received numerous awards for his research, including the American College of Neuropsychopharmacology Memorial Travel Award, American Psychiatric Association Lilly Resident Research Award, the Anxiety Disorders Association of America Trainee Travel Award, and grants from the National Alliance for Research on Schizophrenia and Depression, and the American Foundation for Suicide Prevention. Dr. Mathew has also won several awards for his teaching, and currently serves as the course director for psychopharmacological teaching for PGY2-4 psychiatry residents at Mount Sinai. He completed his residency in psychiatry and postdoctoral research fellowship at Columbia University's College of Physicians and Surgeons, and medical school at Baylor College of Medicine in Houston, TX, his hometown.
In The News
Dr. Mathew discusses mood disorders in The Daily News feature The Daily Check Up. View the PDF.